Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Trading Update and Loan Facility

21 May 2025 16:55

RNS Number : 6617J
Kropz PLC
21 May 2025
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

21 May 2025

Kropz Plc

("Kropz" or the "Company")

 

Trading Update, Loan Facility,

Related Party Transaction & Legal Claim Update

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate producer and developer, announces a trading update for the period to 31 March 2025 and that Kropz Elandsfontein (Pty) Ltd ("Elandsfontein") and ARC Fund ("ARC") (together the "Parties") have agreed to a ZAR 130 million (approximately US$ 6.7 million) loan facility (the "Loan"), which constitutes a related party transaction. The Company also announces agreement of a legal stay on the claim which Kropz and its subsidiary company, Cominco Resources Limited ("Cominco"), are defendants (the "Claim").

 

 

Trading Update

 

Elandsfontein produced 77,318 tonnes of phosphate concentrate during Q1 2025 and had sales of 88,554 tonnes of phosphate concentrate over the same period. This included a record production month of 33,000 tonnes of phosphate concentrate in January 2025.

 

However, the mine is still in its trial production phase and the Company has encountered some challenges during its progression to full production. Elandsfontein produced 28,000 tonnes of phosphate concentrate during April 2025 with no sales in the month due to one sale being delayed due to the receiving vessel arriving at the port in early May 2025. As noted in the Company's announcement on 26 February 2025, the Company is undergoing a number of projects to address these challenges, which has resulted in an increase in capital expenditure requirements at Elandsfontein. This has resulted in a further funding requirement of ZAR 130 million (approximately US$ 6.7 million).

 

The Loan

 

Elandsfontein and ARC have agreed pending formal execution terms for a loan facility of ZAR 130 million (approximately US$ 6.7 million) where interest is payable on the Loan at the South African prime overdraft interest rate plus 6%, nominal per annum and compounded monthly. The Loan is repayable on the earlier of a date as agreed between the Parties or on demand from ARC, on no less than 15 business days' notice. There is no fixed term.

 

Associated with the Loan, a Guarantee, Security Cession and Pledge by Kropz SA (Pty) Ltd was issued in favour of ARC and pending formal execution a Limited Indemnity, Security Cession and Pledge by Kropz Plc will be issued in favour of ARC for all current and future loan facilities made to Elandsfontein.

 

The Loan will be used by Elandsfontein to fund its cashflow and operational expenditure needs.

 

Of the Loan facility, ZAR 50 million was drawn down on 25 April 2025 ("Tranche 1") and ZAR 30 million was drawn down on 9 May 2025 ("Tranche 2").

 

Related Party Transaction

 

The Loan, Tranche 1 and Tranche 2 (the "Transactions") are related party transactions pursuant to Rule 13 of the AIM Rules for Companies. Gerrit Duminy, a director of the Company, is the representative of ARC and has not been involved in the approval of the Transactions by the Company's board. The directors of the Company, who are considered independent for the purposes of the Transactions, having consulted with the Company's nominated adviser, consider the terms of the Transactions at the time they were entered to be fair and reasonable insofar as the Company's shareholders are concerned.

 

Legal Claim Update

 

On 26 February 2025, Kropz announced that Teh Hong Eng Investments Holding Limited ("THE") and Meridian Investment Group PTE. Limited ("Meridian") had served Particulars of Claim in litigation in the English High Court to which Kropz and its subsidiary company, Cominco, are defendants. The litigation relates to an alleged breach of THE's right of first refusal to acquire Cominco shares at the time of Kropz's offer to Cominco's shareholders in November 2018 which resulted in the acquisition by Kropz of the entire issued and to be issued share capital of Cominco, including the acceptance of the offer by THE and Meridian as shareholders of Cominco.

 

Kropz has agreed a legal stay with THE and Meridian in respect of the litigation. The legal stay expires in July 2025.

 

Further updates will be made if necessary in due course.

 

 

For further information visit www.kropz.com or contact:

Kropz Plc

Via Tavistock

Louis Loubser (CEO)

+44 (0) 207 920 3150

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

Ciara Donnelly

 

+44 (0) 20 7383 5100

 

Hannam & Partners

Broker

Andrew Chubb

+44 (0) 20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

 

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

Charmane Russell

Marion Brower

+27 (0) 11 880 3924

charmane@rasc.co.za 

marion@rasc.co.za

 

 

About Kropz Plc

Kropz is an emerging African phosphate producer and developer with projects in South Africa and in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUAVVRVSUVUAR
Date   Source Headline
29th May 20267:00 amRNSTotal Voting Rights
11th May 202610:27 amRNSDrawdown on Bridge Loan Facilities
30th Apr 202612:42 pmRNSECA Approval and Admission Date of Shares
20th Apr 20268:44 amRNSOperational Update
9th Mar 202611:49 amRNSDrawdown on Bridge Loan Facilities
25th Feb 20267:00 amRNSResults of WRAP Offer and Update on Subscription
20th Feb 20264:31 pmRNSWRAP Retail Offer for up to £91,077
20th Feb 20264:30 pmRNSFundraising, Amendment to Loan Terms & Update
26th Jan 202612:56 pmRNSDrawdown on Bridge Loan Facilities
18th Dec 20257:00 amRNSUnaudited Results for Six Months end 30 Sept 2025
17th Dec 20257:00 amRNSLegal Claim Update
9th Dec 20251:08 pmRNSDrawdown on Bridge Loan Facilities
8th Dec 20257:00 amRNSLoan Facility and Related Party Transaction
24th Nov 20257:00 amRNSTrading Update
6th Nov 20251:31 pmRNSResults of General Meeting
31st Oct 20252:41 pmRNSDrawdown on Bridge Loan Facilities
30th Sep 20255:08 pmRNSNotice of GM
29th Sep 20251:49 pmRNSResult of AGM
26th Sep 20254:16 pmRNSFinal Audited Results
4th Sep 20251:08 pmRNSNotice of AGM
27th Aug 202510:10 amRNSDrawdown on Bridge Loan Facilities
13th Aug 202511:21 amRNSDrawdown on Bridge Loan Facilities
30th Jul 20254:31 pmRNSDirector Disclosure Update
22nd Jul 20253:02 pmRNSLegal Claim Update
16th Jul 20251:08 pmRNSDrawdown on Bridge Loan Facilities
14th Jul 20255:04 pmRNSTrading Update and Loan Facility
30th May 20251:24 pmRNSDrawdown on Bridge Loan Facilities
28th May 20253:59 pmRNSFormal Execution of Loan Facility
21st May 20254:55 pmRNSTrading Update and Loan Facility
19th Mar 20257:23 amRNSNotice of Motion application by WWF SA
26th Feb 20257:00 amRNSTrading Update and Notification of Legal Claim
19th Dec 20247:00 amRNSUnaudited Results for Six Months end 30 Sept 2024
6th Nov 20242:00 pmRNSPassing of Lord Renwick of Clifton
4th Nov 20242:08 pmRNSResults of General Meeting
31st Oct 20247:00 amRNSTotal Voting Rights
17th Oct 20247:00 amRNSAdmission of Shares and Total Voting Rights
10th Oct 20244:30 pmRNSReceipt of Exchange Control Approval
30th Sep 20246:03 pmRNSFinal Audited Results
27th Sep 20241:05 pmRNSResult of AGM
20th Sep 202412:57 pmRNSResults of General Meeting
10th Sep 20247:00 amRNSResult of REX Retail Offer, Update on Subscription
3rd Sep 20247:01 amRNSRetail offer to raise up to £1.8 million
3rd Sep 20247:00 amRNSRestructuring, Fundraising, Notice of GM
27th Aug 20247:00 amRNSDrawdown on Bridge Loan Facilities
11th Jul 20247:00 amRNSTrading Update and further loan facility
20th Jun 20247:52 amRNSUpdate Mineral Resource Estimate - Elandsfontein
10th Jun 202411:05 amRNSStatement regarding share price movement
3rd Apr 20244:22 pmRNSDrawdown on Bridge Loan and BNP Loan Update
28th Mar 202412:11 pmRNSDrawdown on Bridge Loan Facilities
28th Mar 20248:22 amRNSUnaudited Results for 12 Months ended 31 Dec 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.